(CNN)The United States Food and Drug Administration cautions that prescription weight reduction medication Belviq may be related to an increased threat of cancer.
“At this time, the reason for the cancer doubts, and we can not conclude that lorcaserin adds to the cancer danger. We desired to make the public mindful of this possible threat. We are continuing to examine the scientific trial outcomes and will interact our last conclusions and suggestions when we have actually finished our evaluation,” the FDA stated in its statement.
The company went on to keep in mind that healthcare specialists need to think about if the advantages of taking lorcaserin surpass the prospective dangers for a client, which clients presently taking the drug ought to talk with their physicians about the capacity increased threat of cancer.
